Corcept Therapeutics (CORT) Earnings Date & Reports

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

CORT is expected to report earnings to rise 9.65% to 18 cents per share on July 30

Corcept Therapeutics CORT Stock Earnings Reports

Q2'25

Est.

$0.19

Q1'25

Beat

by $0.02

Q4'24

Missed

by $0.12

Q3'24

Beat

by $0.13

Q2'24

Beat

by $0.09

The last earnings report on May 05 showed earnings per share of 17 cents, beating the estimate of 15 cents. With 778.69K shares outstanding, the current market capitalization sits at 7.88B.

View a ticker or compare two or three

Compare

CORT